Reviewing Cooper Companies (COO) & Its Rivals

Cooper Companies (NASDAQ:COO – Get Free Report) is one of 511 publicly-traded companies in the “Healthcare Equipment & Supplies” industry, but how does it contrast to its peers? We will compare Cooper Companies to related companies based on the strength of its profitability, analyst recommendations, institutional ownership, dividends, valuation, earnings and risk.

Volatility and Risk

Cooper Companies has a beta of 0.83, indicating that its stock price is 17% less volatile than the S&P 500. Comparatively, Cooper Companies’ peers have a beta of 2.56, indicating that their average stock price is 156% more volatile than the S&P 500.

Institutional and Insider Ownership

24.4% of Cooper Companies shares are held by institutional investors. Comparatively, 40.6% of shares of all “Healthcare Equipment & Supplies” companies are held by institutional investors. 2.1% of Cooper Companies shares are held by company insiders. Comparatively, 14.9% of shares of all “Healthcare Equipment & Supplies” companies are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Analyst Ratings

This is a summary of recent recommendations and price targets for Cooper Companies and its peers, as reported by MarketBeat.

Cooper Companies currently has a consensus price target of $68.60, indicating a potential upside of 12.77%. As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 23.08%. Given Cooper Companies’ peers stronger consensus rating and higher probable upside, analysts clearly believe Cooper Companies has less favorable growth aspects than its peers.

Profitability

This table compares Cooper Companies and its peers’ net margins, return on equity and return on assets.

Valuation & Earnings

This table compares Cooper Companies and its peers top-line revenue, earnings per share (EPS) and valuation.

Cooper Companies has higher revenue and earnings than its peers. Cooper Companies is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.

Summary

Cooper Companies peers beat Cooper Companies on 7 of the 13 factors compared.

About Cooper Companies

(Get Free Report)

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage to health care professionals and patients worldwide. It offers surgical and office products, including endosee endometrial imaging products, fetal pillow cephalic elevation devices for use in cesarean sections, illuminated speculum products, lone star retractor systems, loop electrosurgical excision procedure products, mara water ablation systems, paragard contraceptive IUDs, point-of-care, and uterine positioning products, as well as cryostorage, such as cord blood and cord tissue storage; fertility products and services, such as fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.